PROX2 and cervical carcinoma: The results showed that high expression of MYH1, MYH4, FGG, and DEPP1 was associated with shorter overall survival of patients with cervical cancer; high expression of SULT1E1, RAB3C, CXCR3, and PROX2 was associated with longer overall survival of patients with cervical cancer.